{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T07:51:47Z","timestamp":1778917907315,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,9,18]],"date-time":"2014-09-18T00:00:00Z","timestamp":1410998400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s10067-014-2779-8","type":"journal-article","created":{"date-parts":[[2014,9,17]],"date-time":"2014-09-17T16:56:09Z","timestamp":1410972969000},"page":"457-464","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["A prospective study comparing infection risk and disease activity in children with juvenile idiopathic arthritis treated with and without tumor necrosis factor-alpha inhibitors"],"prefix":"10.1007","volume":"34","author":[{"given":"Heather M.","family":"Walters","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J. A.","family":"Lehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexa","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Ti","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lemonia","family":"Sitaras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna","family":"Cunningham-Rundles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sima S.","family":"Toussi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,18]]},"reference":[{"key":"2779_CR1","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1002\/art.22838","volume":"56","author":"N Ruperto","year":"2007","unstructured":"Ruperto N, Lovell DJ, Cuttica R, Wilkinson N, Woo P, Espada G et al (2007) A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum 56:3096\u20133106","journal-title":"Arthritis Rheum"},{"key":"2779_CR2","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/ard.2007.069484","volume":"67","author":"V Gerloni","year":"2008","unstructured":"Gerloni V, Pontikaki I, Gattinara M, Fantini F (2008) Focus on adverse events of tumour necrosis factor alpha blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients. Ann Rheum Dis 67:1145\u20131152","journal-title":"Ann Rheum Dis"},{"key":"2779_CR3","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJM200003163421103","volume":"342","author":"DJ Lovell","year":"2000","unstructured":"Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ et al (2000) Etanercept in children with polyarticular juvenile rheumatoid arthritis. N Engl J Med 342:763\u2013769","journal-title":"N Engl J Med"},{"key":"2779_CR4","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/art.23427","volume":"58","author":"DJ Lovell","year":"2008","unstructured":"Lovell DJ, Reiff A, Ilowite NT, Wallace CA, Chon Y, Lin S et al (2008) Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis. Arthritis Rheum 58:1496\u20131504","journal-title":"Arthritis Rheum"},{"key":"2779_CR5","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa0706290","volume":"359","author":"DJ Lovell","year":"2008","unstructured":"Lovell DJ, Ruperto N, Goodman S, Reiff A, Jung L, Jarosova K (2008) Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. N Engl J Med 359:810\u2013820","journal-title":"N Engl J Med"},{"key":"2779_CR6","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3899\/jrheum.111555","volume":"39","author":"C Bracaglia","year":"2012","unstructured":"Bracaglia C, Buonuomo PS, Tozzi AE, Pardeo M, Nicolai R, Campana A et al (2012) Safety and efficacy of etanercept in a cohort of patients with juvenile idiopathic arthritis under 4\u00a0years of age. J Rheumatol 39:1287\u20131290","journal-title":"J Rheumatol"},{"key":"2779_CR7","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3109\/s10165-011-0578-5","volume":"22","author":"M Mori","year":"2012","unstructured":"Mori M, Takei S, Imagawa T, Imanaka H, Nerome Y, Higuchi R et al (2012) Safety and efficacy of long-term etanercept in the treatment of methotrexate-refractory polyarticular-course juvenile idiopathic arthritis in Japan. Mod Rheumatol 22:720\u2013726","journal-title":"Mod Rheumatol"},{"key":"2779_CR8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrrheum.2010.142","volume":"6","author":"PJ Hashkes","year":"2010","unstructured":"Hashkes PJ, Uziel Y, Laxer RM (2010) The safety profile of biologic therapies for juvenile idiopathic arthritis. Nat Rev Rheumatol 6:561\u2013571","journal-title":"Nat Rev Rheumatol"},{"key":"2779_CR9","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1093\/cid\/cit489","volume":"57","author":"SS Toussi","year":"2013","unstructured":"Toussi SS, Pan N, Walters HM, Walsh TJ (2013) Infections in children and adolescents with juvenile idiopathic arthritis and inflammatory bowel disease treated with tumor necrosis factor-\u03b1 inhibitors: systematic review of the literature. Clin Infect Dis 57:1318\u20131330","journal-title":"Clin Infect Dis"},{"key":"2779_CR10","first-page":"387","volume":"35","author":"AL Smitten","year":"2008","unstructured":"Smitten AL, Choi HK, Hochberg MC, Suissa S, Simon T, Testa M et al (2008) The risk of hospitalized infection in patients with rheumatoid arthritis. J Rheumatol 35:387\u2013393","journal-title":"J Rheumatol"},{"key":"2779_CR11","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/art.10524","volume":"46","author":"MF Doran","year":"2002","unstructured":"Doran MF, Crowson CS, Pond GR, O\u2019Fallon WM, Gabriel SE (2002) Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 46:2287\u20132293","journal-title":"Arthritis Rheum"},{"key":"2779_CR12","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1136\/ard.2010.128637","volume":"70","author":"K Au","year":"2011","unstructured":"Au K, Reed G, Curtis JR, Kremer J, Jeffrey G, Strand V et al (2011) High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis. Ann Rheum Dis 70:785\u2013791","journal-title":"Ann Rheum Dis"},{"key":"2779_CR13","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1002\/art.34458","volume":"64","author":"T Beukelman","year":"2012","unstructured":"Beukelman T, Xie F, Chen L, Baddley JW, Delzell E, Grijalva CG et al (2012) Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment. Arthritis Rheum 64:2773\u20132780","journal-title":"Arthritis Rheum"},{"key":"2779_CR14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11926-013-0327-1","volume":"15","author":"A Hurd","year":"2013","unstructured":"Hurd A, Beukelman T (2013) Infectious complications in juvenile idiopathic arthritis. Curr Rheumatol Rep 15:327","journal-title":"Curr Rheumatol Rep"},{"key":"2779_CR15","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1002\/art.37866","volume":"65","author":"T Beukelman","year":"2013","unstructured":"Beukelman T, Xie F, Baddley JW, Chen L, Delzell E, Grijalva CG et al (2013) Brief report: incidence of selected opportunistic infections among children with juvenile idiopathic arthritis. Arthritis Rheum 65:1384\u20131389","journal-title":"Arthritis Rheum"},{"key":"2779_CR16","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.semarthrit.2008.10.002","volume":"39","author":"DE Furst","year":"2010","unstructured":"Furst DE (2010) The risk of infections with biologic therapies for rheumatoid arthritis. Semin Arthritis Rheum 39:327\u2013346","journal-title":"Semin Arthritis Rheum"},{"key":"2779_CR17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/01.md.0000180044.19285.9a","volume":"84","author":"NF Crum","year":"2005","unstructured":"Crum NF, Lederman ER, Wallace MR (2005) Infections associated with tumor necrosis factor-alpha antagonists. Medicine (Baltimore) 84:291\u2013302","journal-title":"Medicine (Baltimore)"},{"key":"2779_CR18","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1002\/art.21386","volume":"52","author":"J Listing","year":"2005","unstructured":"Listing J, Strangfeld A, Kary S, Rau R, von Hinueber U, Stoyanova-Scholz M et al (2005) Infections in patients with rheumatoid arthritis treated with biologic agents. Arthritis Rheum 52:3403\u20133412","journal-title":"Arthritis Rheum"},{"key":"2779_CR19","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/BOR.0b013e3282f4b392","volume":"20","author":"J Askling","year":"2008","unstructured":"Askling J, Dixon W (2008) The safety of anti-tumour necrosis factor therapy in rheumatoid arthritis. Curr Opin Rheumatol 20:138\u2013144","journal-title":"Curr Opin Rheumatol"},{"key":"2779_CR20","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/BOR.0b013e3282fa74f7","volume":"20","author":"NM Patkar","year":"2008","unstructured":"Patkar NM, Teng GG, Curtis JR, Saag KG (2008) Association of infections and tuberculosis with antitumor necrosis factor alpha therapy. Curr Opin Rheumatol 20:320\u2013326","journal-title":"Curr Opin Rheumatol"},{"key":"2779_CR21","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/rheumatology\/kel236","volume":"46","author":"C Salliot","year":"2007","unstructured":"Salliot C, Gossec L, Ruyssen-Witrand A, Luc M, Duclos M, Guignard S et al (2007) Infections during tumour necrosis factor-alpha blocker therapy for rheumatic diseases in daily practice: a systematic retrospective study of 709 patients. Rheumatology (Oxford) 46:327\u2013334","journal-title":"Rheumatology (Oxford)"},{"key":"2779_CR22","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/rheumatology\/keg263","volume":"42","author":"S Kroesen","year":"2003","unstructured":"Kroesen S, Widmer AF, Tyndall A, Hasler P (2003) Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy. Rheumatology (Oxford) 42:617\u2013621","journal-title":"Rheumatology (Oxford)"},{"key":"2779_CR23","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","volume":"295","author":"T Bongartz","year":"2006","unstructured":"Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V (2006) Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 295:2275\u20132285","journal-title":"JAMA"},{"key":"2779_CR24","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1002\/art.24777","volume":"60","author":"EH Giannini","year":"2009","unstructured":"Giannini EH, Ilowite NT, Lovell DJ, Wallace CA, Rabinovich CE, Reiff A et al (2009) Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis. Arthritis Rheum 60:2794\u20132804","journal-title":"Arthritis Rheum"},{"key":"2779_CR25","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1136\/ard.2007.087593","volume":"68","author":"G Horneff","year":"2009","unstructured":"Horneff G, De Bock F, Foeldvari I, Girschick HJ, Michels H, Moebius D et al (2009) Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry. Ann Rheum Dis 68:519\u2013525","journal-title":"Ann Rheum Dis"},{"key":"2779_CR26","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1007\/s00296-011-2030-8","volume":"32","author":"O Kilic","year":"2012","unstructured":"Kilic O, Kasapcopur O, Camcioglu Y, Cokugras H, Arisoy N, Akcakaya N (2012) Is it safe to use anti-TNF-\u03b1 agents for tuberculosis in children suffering with chronic rheumatic disease? Rheumatol Int 32:2675\u20132679","journal-title":"Rheumatol Int"},{"key":"2779_CR27","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1086\/421494","volume":"39","author":"AK Mohan","year":"2004","unstructured":"Mohan AK, Cot\u00e9 TR, Block JA, Manadan AM, Siegel JN, Braun MM (2004) Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor. Clin Infect Dis 39:295\u2013299","journal-title":"Clin Infect Dis"},{"key":"2779_CR28","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1086\/383317","volume":"38","author":"RS Wallis","year":"2004","unstructured":"Wallis RS, Broder MS, Wong JY, Hanson ME, Beenhouwer DO (2004) Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis 38:1261\u20131265","journal-title":"Clin Infect Dis"},{"key":"2779_CR29","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10067-008-1067-x","volume":"28","author":"O Elbek","year":"2009","unstructured":"Elbek O, Uyar M, Aydin N, Borekci S, Bayram N, Bayram H et al (2009) Increased risk of tuberculosis in patients treated with antitumor necrosis factor alpha. Clin Rheumatol 28:421\u2013426","journal-title":"Clin Rheumatol"},{"key":"2779_CR30","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/rheumatology\/keh074","volume":"43","author":"W Armbrust","year":"2004","unstructured":"Armbrust W, Kamphuis SSM, Wolfs TWF, Fiselier TJW, Nikkels PG, Kuis W et al (2004) Tuberculosis in a nine-year-old girl treated with infliximab for systemic juvenile idiopathic arthritis. Rheumatology (Oxford) 43:527\u2013529","journal-title":"Rheumatology (Oxford)"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2779-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-014-2779-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2779-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:57:37Z","timestamp":1559120257000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-014-2779-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,18]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["2779"],"URL":"https:\/\/doi.org\/10.1007\/s10067-014-2779-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,18]]}}}